Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Diabetologia
Erschienen in: Diabetologia 11/2006

01.11.2006 | Article

Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease—evaluation by contrast echocardiography and pulsed tissue Doppler

verfasst von: V. Dounis, T. Siegmund, A. Hansen, J. Jensen, P.-M. Schumm-Draeger, H. von Bibra

Erschienen in: Diabetologia | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Using modern echocardiography, we quantified the extent of global myocardial function and perfusion abnormalities in patients with type 2 diabetes and compared this with the hypothetically similar extent of impairments in patients with coronary artery disease (CAD).

Subjects and methods

This case–control study (66 patients) compared four age-matched groups: control, type 2 diabetic, CAD, and diabetic subjects with CAD (DCAD) and left ventricular ejection fraction >50%. CAD patients had 1–2 vessel disease. Diastolic and systolic myocardial velocities were assessed with pulsed tissue Doppler. Global myocardial perfusion was assessed with contrast echocardiography as indices of capillary blood volume and myocardial blood flow at maximal vasodilatation. In CAD and DCAD patients, functional and perfusion parameters were additionally assessed in the territory with a normal coronary angiogram reading, providing a model for comparison with the global data from control and diabetic patients.

Results

Comparing diabetic with control subjects, myocardial velocity at early diastole was impaired (8.8±1.8 vs 10.1±1.7 cm/s; p=0.02) and correlated inversely with age, HbA1c and pulse pressure (R 2=0.761). Capillary blood volume (16.6±5.0 vs 24.4±4.9%) and blood flow (56±35 vs 114±40) were decreased (p=0.001). In CAD patients, myocardial velocity at early diastole was similarly decreased (p=0.02). CAD and DCAD patients were receiving more cardiovascular preventive therapy for the same extent of impaired global perfusion as in the less extensively treated diabetes group without CAD (p<0.002), but had superior perfusion of the ‘normal’ coronary territory than that group (p<0.05).

Conclusions/interpretation

In patients with diabetes, global diastolic function and myocardial capillary blood volume and blood flow are impaired to the same extent as in patients with CAD. These impairments could form the basis of new therapeutic concepts.
Literatur
1.
DECODE study group on behalf of the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 354:617–621CrossRef
2.
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham Study. J Am Med Assoc 214:2035–2038CrossRef
3.
Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Rydén L (2003) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144CrossRef
4.
Grundy SM, Benjamin IJ, Burke GL et al (1999) Diabetes and cardiovascular disease. AHA scientific statement for healthcare professionals from the American Heart Association. Circulation 100:1134–1146PubMed
5.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. ADA Diabetes classification (2005). Diabetes Care 28(Suppl 1):1–79
6.
Doran JH, Trail TA, Brown DJ, Gibson DG (1978) Detection of abnormal left ventricular wall movement during isovolumic contraction and early relaxation. Br Heart J 40:367–371PubMed
7.
Garcia MJ, Thomas JD, Klein AL (1998) New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32:865–875PubMedCrossRef
8.
Celentano A, Vaccaro O, Tammaro P et al (1995) Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol 76:1173–1176PubMedCrossRef
9.
Liu JE, Palmieri V, Roman MJ et al (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37:1943–1949PubMedCrossRef
10.
Nahser PJ, Brown RE, Oskarsson H et al (1995) Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes. Circulation 91:6635–6640
11.
Strauer BE, Motz W, Vogt M, Schwartzkopf B (1997) Impaired coronary flow reserve in NIDD. A possible role for diabetic cardiomyopathy in humans. Diabetes 46(Suppl 2):119–124
12.
Pitkänen O-P, Nuutila P, Raitakari OT et al (1998) Coronary flow reserve is reduced in young men with IDD. Diabetes 47:248–254PubMed
13.
von Bibra H, Tuchnitz A, Klein A et al (2000) Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischaemia during pharmacologic stress testing—a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol 36:444–452CrossRef
14.
Fang ZY, Yuda S, Anderson V et al (2003) Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41:611–617PubMedCrossRef
15.
Porter TR, Xie F, Silver M et al (2001) Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging. J Am Coll Cardiol 37:748–753PubMedCrossRef
16.
von Bibra H, Bone D, Niklasson U et al (2002) Myocardial contrast echocardiography yields best accuracy using quantitative analysis of digital data from pulse inversion technique comparison with second harmonic imaging and harmonic power Doppler during simultaneous dipyridamole stress SPECT studies. Eur J Echocardiog 3:271–282CrossRef
17.
Wei K, Jayaweera AR, Firoozan S et al (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473–483PubMed
18.
Dawson D, Vincent MA, Barrett EJ et al (2002) Vascular recruitment in skeletal muscle during exercise and hyperinsulinaemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab 282:E714–E720PubMed
19.
Wu CC, FelDan MD, Mills JD et al (1997) Myocardial contrast echocardiography can be used to quantify intramyocardial blood volume: new insights into structural mechanisms of coronary autoregulation. Circulation 96:1004–1011PubMed
20.
Hansen A, Johansson BL, Wahren J, von Bibra H (2002) Beneficial effects of C-peptide on myocardial function in patients with type 1 diabetes. Diabetes 51:3077–3082PubMed
21.
American Society of Echocardiography Committee on Standards, subcommittee on Quantification of Two Dimensional Echocardiograms (1989) Recommendations for the left ventricle by two dimensional echocardiography. J Am Soc Echocardiog 2:258–267
22.
Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446–2452PubMedCrossRef
23.
von Bibra H, Thrainsdottir IS, Hansen A, Dounis V, Malmberg K, Rydén L (2005) Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus: a methodological study. Diabetes Vasc Dis Res 2:483–487
24.
Lang RM, Bierig M, Devereux RB et al (2006) Recommendations for chamber quantification. Eur J Echocardiog 7:79–108CrossRef
25.
Jain A, Avendano G, Dharamsey S et al (1996) Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with the diabetic heart. Circulation 93:1396–1402PubMed
26.
Vinereanu D, Nicolaides E, Tweddel A et al (2003) Subclinical left ventricular dysfunction in asymptomatic patients with type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci 2003 105:591–599CrossRef
27.
Brownlee M (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835–1843PubMed
28.
Mizushige K, Yao L, Noma T et al (2000) Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type 2 diabetic rat model. Circulation 101:899–907PubMed
29.
Diamant M, Lamb HJ, Groeneveld Y et al (2003) Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42:328–335PubMedCrossRef
30.
von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Rydén L (2004) Insulin based improved metabolic control augments myocardial diastolic function and perfusion in patients with type 2 diabetes mellitus. Heart 90:1483–1484CrossRef
31.
Bella JN, Palmieri V, Roman MJ et al (2002) Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults. The Strong Heart Study. Circulation 105:1928–1933PubMedCrossRef
32.
Wang M, Yip G, Wanf A et al (2003) Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 43:820–826CrossRef
33.
Henein M, Lindqvist P, Francis D et al (2002) Tissue Doppler analysis of age-dependency in diastolic ventricular behaviour and filling. A cross-sectional study of healthy hearts (the Umea General Population Heart Study). Eur Heart J 23:162–171PubMedCrossRef
34.
Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part 1: Aging arteries: a set up for vascular disease. Circulation 107:139–148PubMedCrossRef
35.
Dart AM, Kingwell BA (2001) Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol 37:975–984PubMedCrossRef
36.
Leite-Moreira AF, Correia-Pinto J, Gillebert TC (1999) Afterload induced changes in myocardial relaxation. A mechanism for diastolic dysfunction. Cardiovasc Res 43:344–533PubMedCrossRef
37.
Vinereanu D, Nicolaides E, Boden L et al (2003) Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 89:449–450PubMedCrossRef
38.
Heart outcomes prevention evaluation (HOPE) study investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253–259CrossRef
39.
Vincent MA, Dawson D, Clark A et al (2002) Skeletal muscle microvascular recruitment by physiological hyperinsulinaemia precedes increases in total blood flow. Diabetes 51:42–48PubMed
40.
Wiernsperger NF (2001) In defence of microvascular constriction in diabetes. Clin Hemorheol Microcirc 25:55–62PubMed
41.
Williams SB, Goldfine AB, Timimi FK et al (1998) Acute hyperglycaemia attenuates endothelium-dependent vasodilatation in humans in vivo. Circulation 97:1695–1701PubMed
42.
Ceriello A, Taboga C, Tonuti L et al (2002) Evidence for an independent and cumulative effect of postprandial hypertriglyceridaemia and hyperglycaemia on endothelial dysfunction and oxidative stress generation. Circulation 106:1211–1218PubMedCrossRef
43.
Rask-Madsen C, Ihleman N, Krarup T et al (2001) Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 50:2611–2618PubMed
44.
Bartnik M, Malmberg K, Norhammar A, Tenerz A, Öhrvik J, Rydén L (2004) Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25:1990–1997PubMedCrossRef
45.
Satoh H, Terada H, Uehara A et al (2005) Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus. Heart 91:731–736PubMedCrossRef
46.
Kowalska I, Prokop J, Bachorzewska-Gajewska H et al (2001) Disturbances of glucose metabolism in men referred for coronary arteriography. Diabetes Care 24:897–901PubMed
47.
Wykretowicz A, Guzik P, Bartkowiak G et al (2005) Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels. Clin Sci 109:397–403CrossRef
48.
Rathmann W, Haastert B, Icks A et al (2003) High prevalence of undiagnosed diabetes mellitus in southern Germany: target populations for efficient screening. the KORA survey. Diabetologia 46:182–189PubMed
49.
Harris MI, Flegal K, Cowie CC et al (1998) Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance. Diabetes Care 21:518–524PubMed
Metadaten
Titel
Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease—evaluation by contrast echocardiography and pulsed tissue Doppler
verfasst von
V. Dounis
T. Siegmund
A. Hansen
J. Jensen
P.-M. Schumm-Draeger
H. von Bibra
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 11/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0398-x

Weitere Artikel der Ausgabe 11/2006

Diabetologia 11/2006 Zur Ausgabe

Letter

Comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia; 49: 837–845

Article

Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats

Commentary

How to make beta cells from embryonic cells

Article

Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

Article

Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats

Letter

Comment on: Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise